Paclitaxel-releasing mesenchymal stromal cells inhibit in vitro proliferation of human mesothelioma cells-Reference-Cited by-同舟云学术

Paclitaxel-releasing mesenchymal stromal cells inhibit in vitro proliferation of human mesothelioma cells

Published:2017-03 Issue: Volume:87 Page:755-758
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Petrella Francesco,Coccè Valentina,Masia Carla,Milani Martina,Salè Emanuela Omodeo,Alessandri Giulio,Parati Eugenio,Sisto Francesca,Pentimalli Francesca,Brini Anna T.,Pessina Augusto,Spaggiari Lorenzo

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference14 articles.

1. Pleural tumors;McNamee,2014

2. Ths epidemiology of mesothelioma;Britton;Semin. Oncol.,2002

3. The third italian consensus conference for malignant pleural mesothelioma: state of the art and recommendations;Novello;Crit. Rev. Oncol. Hematol.,2016

4. Chemotherapy in malignant mesothelioma: a review;Krauf-Hansen;Cancer Chemother. Pharmacol.,2016

5. Paclitaxel for malignant pleural mesothelioma: a phase II study of the EORTC Lung Cancer Cooperative Group;van Meerbeeck;Br. J. Cancer,1996

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bioengineered Mesenchymal Stem/Stromal Cells in Anti-Cancer Therapy: Current Trends and Future Prospects;Biomolecules;2024-06-21

2. Small extracellular vesicles: Multi-functional aspects in non-small cell lung carcinoma;Critical Reviews in Oncology/Hematology;2024-06

3. Therapeutic Strategies to Improve the Treatment of Pleural Mesothelioma;Current Medicinal Chemistry;2024-04-16

4. Nanotechnology and bioengineering approaches to improve the potency of mesenchymal stem cell as an off‐the‐shelf versatile tumor delivery vehicle;Medicinal Research Reviews;2024-02

5. Human Pluripotent Stem Cell-Derived Mesenchymal Stem Cells for Oncotherapy;Advances in Pluripotent Stem Cells;2024-01-31